瓦克斯特公司
US ˙ OTCPK ˙ US92243A2006

簡介

本頁面提供了有關 Todd C Davis 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Todd C Davis已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
Director 39,886
US:LGND / Ligand Pharmaceuticals Incorporated Chief Executive Officer, Director 199,381
Director 112,547
US:VXRT / Vaxart, Inc. Director 125,905
US:BDSI / Biodelivery Sciences International Director 0
如何解讀這些圖表

以下圖表顯示了在Todd C Davis進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

VXRT / Vaxart, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 VXRT / Vaxart, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

VXRT / Vaxart, Inc. Insider Trades
VXRT / Vaxart, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 VXRT / Vaxart, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
2020-04-28 VXRT Davis Todd C 60,000 3.2750 60,000 3.2750 196,500 44 2.2600 -60,900 -30.99

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

VXRT / Vaxart, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Todd C Davis 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-04-01 2025-07-02 4/A PTHS Pelthos Therapeutics Inc.
Common Stock
A - Award 19,108 39,886 91.96
2026-04-01 2024-11-13 4/A PTHS Pelthos Therapeutics Inc.
Common Stock
A - Award 4,961 20,778 31.36
2026-04-01 2024-06-14 4/A PTHS Pelthos Therapeutics Inc.
Common Stock
A - Award 12,900 15,817 442.24
2026-03-27 2026-03-02 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 10,495 199,381 5.56
2026-02-18 2026-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2,805 188,886 -1.46 183.83 -515,643 34,722,913
2026-02-18 2026-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -4,255 191,691 -2.17 183.83 -782,197 35,238,557
2026-02-18 2026-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2,039 195,946 -1.03 183.83 -374,829 36,020,753
2026-02-18 2026-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -15,600 197,985 -7.30 183.83 -2,867,748 36,395,583
2026-02-18 2026-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 39,644 213,585 22.79
2026-02-18 2026-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -8,178 173,941 -4.49 183.83 -1,503,362 31,975,574
2026-02-18 2026-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 20,782 182,119 12.88
2025-12-08 2025-12-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
G - Gift -130 161,337 -0.08
2025-07-03 2025-07-01 4 PTHS Pelthos Therapeutics Inc.
Common Stock
C - Conversion 1,500,000 1,500,000 10.00 15,000,000 15,000,000
2025-07-02 2025-06-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 233 161,467 0.14 91.08 21,221 14,706,011
2025-05-13 2025-05-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 5,523 161,234 3.55 105.67 583,629 17,038,000
2025-05-13 2025-05-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 2,307 155,711 1.50 104.53 241,150 16,276,393
2025-05-13 2025-05-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 1,680 153,404 1.11 104.57 175,678 16,041,456
2025-03-06 2025-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 21,382 151,724 16.40
2025-02-19 2025-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -4,255 130,342 -3.16 120.00 -510,600 15,641,040
2025-02-19 2025-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2,231 134,597 -1.63 120.00 -267,720 16,151,640
2025-02-19 2025-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -6,966 136,828 -4.84 120.00 -835,920 16,419,360
2025-02-19 2025-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 20,784 143,794 16.90
2024-12-16 3 PVLA PALVELLA THERAPEUTICS, INC.
Common Stock
112,547
2024-08-09 2024-08-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 2,500 123,010 2.07 97.39 243,480 11,980,215
2024-07-02 2024-06-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 350 120,510 0.29 60.71 21,247 7,315,801
2024-03-27 2024-03-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 3,556 120,160 3.05 66.19 235,372 7,953,390
2024-03-27 2024-03-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 2,156 116,604 1.88 68.51 147,708 7,988,540
2024-03-27 2024-03-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 2,855 114,448 2.56 67.24 191,970 7,695,484
2024-03-27 2024-03-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 7,448 111,593 7.15 46.20 344,098 5,155,597
2024-02-29 2024-02-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 32,436 104,145 45.23
2024-02-23 2024-02-21 4 CHRO Chromocell Therapeutics Corp
Common Stock
M - Exercise 29,167 29,167 4.80 140,002 140,002
2024-02-16 2024-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,381 71,709 -1.89 74.65 -103,092 5,353,077
2023-09-25 2023-09-22 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 4,000 73,090 5.79 59.38 237,529 4,340,245
2023-06-13 2023-06-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -420 69,090 -0.60 73.76 -30,979 5,096,078
2023-02-27 2023-02-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 17,005 68,791 32.84
2022-08-08 2022-08-04 4 VXRT Vaxart, Inc.
Common Stock
A - Award 7,375 125,905 6.22
2022-06-13 2022-06-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 1,004 51,786 1.98
2022-03-22 2022-03-22 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Options (right to buy)
D - Sale to Issuer -85,760 0 -100.00
2022-03-22 2022-03-22 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Options (right to buy)
D - Sale to Issuer -48,123 0 -100.00
2022-03-22 2022-03-22 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units
D - Sale to Issuer -22,685 0 -100.00
2022-03-22 2022-03-22 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
J - Other -252,207 0 -100.00
2022-02-01 2022-01-27 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units
M - Exercise -7,684 7,685 -50.00
2022-02-01 2022-01-27 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units
A - Award 15,369 15,369
2022-02-01 2022-01-27 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Options (right to buy)
A - Award 85,760 85,760 3.66 313,882 313,882
2022-02-01 2022-01-27 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
M - Exercise 7,684 252,207 3.14
2021-12-23 2021-12-22 4 VXRT Vaxart, Inc.
Common Stock
G - Gift -1,470 118,530 -1.22
2021-08-10 2021-08-06 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units
M - Exercise -30,000 15,000 -66.67
2021-08-10 2021-08-06 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
M - Exercise 30,000 244,523 13.98
2021-06-17 2021-06-16 4 VXRT Vaxart, Inc.
Stock Option (right to buy)
A - Award 15,097 15,097
2021-06-14 2019-11-18 4/A VXRT Vaxart, Inc.
Stock Option (right to buy)
A - Award 54,720 54,720
2021-06-07 2021-06-04 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 3,269 3,269
2021-06-07 2021-06-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 630 50,782 1.26
2021-02-16 2018-12-26 5 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
G - Gift -3,391 214,523 -1.56
2021-02-12 2021-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -2,474 0 -100.00
2021-02-12 2021-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 2,474 50,152 5.19 195.91 484,681 9,825,278
2021-02-12 2021-02-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -5,083 47,678 -9.63 213.14 -1,083,410 10,162,270
2021-01-27 2021-01-27 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -2,456 0 -100.00
2021-01-27 2021-01-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 2,456 52,761 4.88 113.50 278,756 5,988,374
2020-08-20 2020-08-18 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
S - Sale -50,000 217,914 -18.66 4.99 -249,500 1,087,391
2020-08-11 2020-08-07 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units
M - Exercise -30,000 45,000 -40.00
2020-08-11 2020-08-07 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
M - Exercise 30,000 267,914 12.61
2020-06-12 2020-06-10 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 2,468 2,468
2020-06-12 2020-06-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 831 50,305 1.68
2020-06-09 2020-06-08 4 VXRT Vaxart, Inc.
Stock Option (right to buy)
A - Award 65,700 65,700
2020-04-30 2020-04-28 4 VXRT Vaxart, Inc.
Common stock
S - Sale -60,000 120,000 -33.33 3.28 -196,500 393,000
2020-04-30 3/A VXRT Vaxart, Inc.
Common stock
180,000
2019-11-20 2019-11-18 4 VXRT Vaxart, Inc.
Stock Option (right to buy)
A - Award 54,720 54,720
2019-11-19 2019-11-15 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
S - Sale -200,000 237,914 -45.67 6.11 -1,222,000 1,453,655
2019-08-15 2019-08-13 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units
M - Exercise -18,123 75,000 -19.46
2019-08-15 2019-08-13 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
M - Exercise 18,123 437,914 4.32
2019-08-05 2019-08-02 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 1,000 49,474 2.06 93.59 93,594 4,630,489
2019-06-07 2019-06-06 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 4,071 4,071
2019-06-07 2019-06-06 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 835 48,474 1.75
2018-10-15 2018-10-12 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -2,329 0 -100.00
2018-10-15 2018-10-12 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -2,754 0 -100.00
2018-10-15 2018-10-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 2,329 47,639 5.14 119.30 277,850 5,683,333
2018-10-15 2018-10-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 2,754 45,310 6.47 89.75 247,172 4,066,572
2018-10-09 2018-10-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -2,500 42,556 -5.55 253.99 -634,978 10,808,850
2018-08-24 2018-08-24 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Series B Convertible Preferred Stock
C - Conversion -75 0 -100.00
2018-08-24 2018-08-24 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
C - Conversion 416,667 419,791 13,337.61
2018-08-17 2018-08-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -3,167 45,056 -6.57 239.50 -758,496 10,790,912
2018-08-17 2018-08-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -5,833 48,223 -10.79 239.93 -1,399,505 11,570,091
2018-08-16 2018-08-14 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units
M - Exercise -3,124 93,123 -3.25
2018-08-16 2018-08-14 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
M - Exercise 3,124 3,124
2018-08-03 2018-08-01 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Options (right to buy)
A - Award 48,123 48,123
2018-08-03 2018-08-01 4 BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units
A - Award 96,247 96,247
2018-07-03 2018-06-19 4/A LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 2,474 2,474
2018-06-21 2018-06-19 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 2,474 2,474
2018-06-21 2018-06-19 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 493 54,056 0.92
2018-02-27 2018-02-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -12,335 53,563 -18.72 151.90 -1,873,709 8,136,316
2018-02-27 2018-02-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -4,835 65,898 -6.84 153.58 -742,536 10,120,292
2017-12-27 2017-12-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
G - Gift -74 70,733 -0.10
2017-05-26 2017-05-25 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 2,456 2,456 113.50 278,756 278,756
2017-05-26 2017-05-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 666 70,807 0.95
2016-12-29 2016-12-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
G - Gift -48 70,141 -0.07
2016-11-01 2016-10-31 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -3,312 0 -100.00
2016-11-01 2016-10-31 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -3,333 0 -100.00
2016-11-01 2016-10-31 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -7,335 0 -100.00
2016-11-01 2016-10-31 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 3,312 70,189 4.95 67.53 223,659 4,739,863
2016-11-01 2016-10-31 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 7,335 66,877 12.32 32.30 236,920 2,160,127
2016-11-01 2016-10-31 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 3,333 59,542 5.93 53.34 177,782 3,175,970
2016-05-25 2016-05-23 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 2,329 2,329 119.30 277,850 277,850
2016-05-25 2016-05-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 188 56,209 0.34
2016-05-25 2016-05-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 622 56,021 1.12
2015-12-09 2015-12-07 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
G - Gift -50 55,399 -0.09
2015-08-06 2015-08-06 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -2,500 0 -100.00
2015-08-06 2015-08-06 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -2,500 0 -100.00
2015-08-06 2015-08-06 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -7,335 0 -100.00
2015-08-06 2015-08-06 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -7,335 0 -100.00
2015-08-06 2015-08-06 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 7,335 55,449 15.25 12.53 91,908 694,776
2015-08-06 2015-08-06 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 7,335 48,114 17.99 10.12 74,230 486,914
2015-08-06 2015-08-06 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 2,500 40,779 6.53 8.58 21,450 349,884
2015-08-06 2015-08-06 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 2,500 38,279 6.99 17.88 44,700 684,429
2015-04-27 2015-04-24 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 2,754 2,754 89.75 247,172 247,172
2015-04-27 2015-04-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 501 35,779 1.42
2015-04-27 2015-04-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 925 35,278 2.69
2014-06-05 2014-06-04 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 3,312 3,312 67.53 223,659 223,659
2014-06-05 2014-06-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 666 34,353 1.98
2014-06-05 2014-06-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 1,151 33,687 3.54
2014-03-20 2014-03-19 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -5,000 32,536 -13.32 79.63 -398,147 2,590,822
2014-03-20 2014-03-18 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -2,500 37,536 -6.24 79.45 -198,637 2,982,419
2013-06-12 2013-06-11 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 7,335 7,335 32.30 236,920 236,920
2013-06-12 2013-06-11 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 1,393 40,036 3.60
2013-06-12 2013-06-11 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 2,925 38,643 8.19
2012-05-31 2012-05-31 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 7,335 7,335
2012-05-31 2012-05-31 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 3,592 35,718 11.18
2012-05-31 2012-05-31 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 2,925 32,126 10.02
2007-03-05 2007-03-01 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 20,000 20,000
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)